Patents by Inventor Satyanarayana Janagani

Satyanarayana Janagani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Expedient synthesis of sitagliptin
    Patent number: 9938282
    Abstract: Novel intermediates are disclosed as intermediates for preparation of a Sitagliptin. A novel synthetic method to prepare Sitagliptin using the said intermediates is also disclosed.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: April 10, 2018
    Assignee: STEREOKEM, INC.
    Inventors: Satyanarayana Janagani, Venkateshwar Kumar Thaduri, Ravisankar Vamaraju
  • EXPEDIENT SYNTHESIS OF SITAGLIPTIN
    Publication number: 20170183351
    Abstract: Novel intermediates are disclosed as intermediates for preparation of a Sitagliptin. A novel synthetic method to prepare Sitagliptin using the said intermediates is also disclosed.
    Type: Application
    Filed: February 5, 2015
    Publication date: June 29, 2017
    Inventors: Satyanarayana JANAGANI, Venkateshwar Kumar THADURI, Ravisankar VAMARAJU
  • 2-Substituted and 4-substituted aryl nitrone compounds
    Publication number: 20100168112
    Abstract: The present invention provides aryl nitrones, compositions comprising the same and methods of their use for the treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine mediated conditions.
    Type: Application
    Filed: July 15, 2009
    Publication date: July 1, 2010
    Inventors: Michael G. KELLY, John Kincaid, Satyanarayana Janagani
  • Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
    Publication number: 20100004222
    Abstract: Compounds are disclosed that have a formula represented by the following: Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: February 22, 2007
    Publication date: January 7, 2010
    Applicant: Renovis, Inc.
    Inventors: Michael G. Kelly, Carl J. Kaub, John Kincaid, Satyanarayana Janagani, Guoxian Wu, Zhi-Liang Wei, Kiran Sahasrabudhe, Matthew Duncton, Ravindra B. Upasani, Yunfeng Fang, Matthew Cox, Jianhua He
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Patent number: 7576099
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: August 18, 2009
    Assignee: Renovis, Inc.
    Inventors: Michael G. Kelly, John Kincaid, Matthew Duncton, Kiran Sahasrabudhe, Satyanarayana Janagani, Ravindra B. Upasani, Guoxian Wu, Jianhua He, legal representative, Zhi-Liang Wei, Carl Kaub, YunFeng Fang
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Publication number: 20080312237
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: July 18, 2008
    Publication date: December 18, 2008
    Inventors: Michael G. Kelly, Satyanarayana Janagani, Ravindra B. Upasani
  • Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
    Publication number: 20080300243
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: February 24, 2006
    Publication date: December 4, 2008
    Inventors: Michael G. Kelly, John Kincaid, Matthew Duncton, Kiran Sahasrabudhe, Satyanarayana Janagani, Ravindra B. Upasani, Guoxian Wu, YunFeng Fang, Zhi-Liang Wei, Carl Kaub, Jianhua He
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Patent number: 7432281
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: October 7, 2008
    Assignee: Renovis, Inc.
    Inventors: Michael G. Kelly, Satyanarayana Janagani, Ravindra B. Upasani
  • Amide compounds as ion channel ligands and uses thereof
    Publication number: 20080200524
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: November 1, 2007
    Publication date: August 21, 2008
    Inventors: Michael G. Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid
  • Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
    Patent number: 7414131
    Abstract: Amine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: August 19, 2008
    Assignee: Renovis, Inc.
    Inventors: Michael G. Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid, David Lonergan, YunFeng Fang, Zhi-Liang Wei
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Publication number: 20080096919
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: August 23, 2007
    Publication date: April 24, 2008
    Inventors: Michael Kelly, John Kincaid, Satyanarayana Janagani, Matthew Duncton
  • Amide compounds as ion channel ligands and uses thereof
    Patent number: 7338950
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: March 4, 2008
    Assignee: Renovis, Inc.
    Inventors: Michael G. Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Patent number: 7312233
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: December 25, 2007
    Assignee: Renovis, Inc.
    Inventors: Michael G. Kelly, John Kincaid, Satyanarayana Janagani, Matthew Duncton
  • Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
    Patent number: 7312330
    Abstract: Amine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Grant
    Filed: May 4, 2005
    Date of Patent: December 25, 2007
    Assignee: Renovis, Inc.
    Inventors: Michael G. Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid, David Lonergan, YunFeng Fang, Zhi-Liang Wei
  • Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
    Publication number: 20070275932
    Abstract: Disclosed are aryl, heteroaromatic and bicyclic aryl nitrone compounds and pharmaceutical compositions containing such derivatives. The disclosed compositions are useful for preventing and/or treating pain, neurodegenerative, autoimmune and inflammatory diseases or conditions in mammals.
    Type: Application
    Filed: December 8, 2006
    Publication date: November 29, 2007
    Inventors: Michael Kelly, Satyanarayana Janagani, Ravindra Upasani
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Publication number: 20060205773
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: March 14, 2006
    Publication date: September 14, 2006
    Inventors: Michael Kelly, John Kincaid, Satyanarayana Janagani, Matthew Duncton
  • Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
    Publication number: 20060194801
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: February 24, 2006
    Publication date: August 31, 2006
    Inventors: Michael Kelly, John Kincaid, Matthew Duncton, Kiran Sahasrabudhe, Satyanarayana Janagani, Ravindra Upasani, Guoxian Wu, Yunfeng Fang, Zhi-Liang Wei
  • Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
    Publication number: 20050277643
    Abstract: Amine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: May 4, 2005
    Publication date: December 15, 2005
    Inventors: Michael Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid, David Lonergan, YunFeng Fang, Zhi-Liang Wei
  • Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
    Publication number: 20050215572
    Abstract: Amine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: December 23, 2004
    Publication date: September 29, 2005
    Inventors: Michael Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid, David Lonergan, YunFeng Fang, Zhi-Liang Wei
  • Amide compounds as ion channel ligands and uses thereof
    Publication number: 20050197364
    Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    Type: Application
    Filed: October 7, 2004
    Publication date: September 8, 2005
    Inventors: Michael Kelly, Satyanarayana Janagani, Guoxian Wu, John Kincaid